ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: Implications for t(8;21) leukemogenesis and monitoring residual disease

Blood

Volumn 88, Issue 5, 1996, Pages 1813-1823

  Erickson, Paul F ^b   Dessev, George ^b   Lasher, Robert S ^b   Philips, George ^b   Robinson, Misi ^b   Drabkin, Harry A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CHIMERIC PROTEIN; PHOSPHOAMINO ACID; PHOSPHOPROTEIN; SERINE; THREONINE; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL STRAIN K 562; CHROMOSOME 21; CHROMOSOME TRANSLOCATION 8; CLINICAL PROTOCOL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPEROXIDASE STAINING; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MEGAKARYOCYTE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0029844799     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1813.bloodjournal8851813     Document Type: Article

References (37)

1. Mitelman F, Heim S: Quantitative acute leukemia cytogenetics. Genes Chromosome Cancer 5:57, 1992
2. Gao J, Erickson P, Gardiner K, Le Beau MM, Diaz MO, Patterson D, Rowley JD, Drabkin HA: Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q2.3) in acute myelogenous leukemia. Proc Natl Acad Sci USA 88:4882, 1991
3. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431, 1991
4. Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H: Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML/ETO, with similarity to drosophila segmentation gene, runt. Blood 80:1825, 1992
5. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M: The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 12:2715, 1993
6. Erickson PF, Robinson M, Owens G, Drabkin HA: The ETO portion of AML t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res 54:1782, 1994
7. Nucifora G, Rowley JD: AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1, 1995
8. Era T, Asou N, Kunisada T, Yamasaki H, Asou H, Kamada N, Nishikawa S-I, Yamaguchi K, Takatsuki K: Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosomes Cancer 13:25, 1995
9. H gene segments. Cell 40:271, 1985
10. Boehm T, Mengle-Gaw L, Kees UR, Spurr N, Lavenir I, Forster A, Rabbitts TH: Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumors. EMBO J 8:2621, 1989
11. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M, Ito Y: Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809, 1993
12. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y: PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and human AML1 gene. Proc Natl Acad Sci USA 90:6859, 1993
13. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y: AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425, 1994
14. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N: Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 77:2031, 1991
15. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321, 1975
16. Martin P, Papayannopoulou T: HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216:1233, 1982
17. Bates RC, Buret A, van Helden DF, Horton MA, Burns GF: Apoptosis induced by inhibition of intercellular contact. J Cell Biol 125:403, 1994
18. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:403, 1970
19. Fulop MJ, Webber T, Manchee RJ: Use of a zwitterionic detergent for the restoration of the antibody binding capacity of immunoblotted Fracisella talarensis lipopolysaccharide. Anal Biochem 203:141, 1992
20. Sefton BM, Beemon K, Hunter T: Comparison of the expression of the src gene of Rous Sarcoma virus in vitro and in vivo. J Virol 28:957, 1978
21. Boyle WJ, van der Geer P, Hunter T: Phosphopeptide mapping and phophoamino acid analysis by two-dimensional separation on thin layer cellulose plates. Methods Enzymol 201:110, 1991
22. Erickson P, Robinson M, Drabkin HA: Nuclear localization of the t(8;21) AML protein. AML1/ETO. in cells having cytoplasmic AML1. J Cell Biochem 19A:51, 1995 (abstr, suppl)
23. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypic characteristics of acute myeloid leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470, 1991
24. Morishita K, Parganas E, Matsugi T, Ihle JN: Expression of the EVI1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 12:183, 1992
25. Meyers S, Lenny N, Hiebert SW: The t(8;21) fusion protein interferes with AML1-1B-dependent transcriptional activation. Mol Cell Biol 15:1974, 1995
26. Green AR, Rockman S, DeLuca E, Begley CG: Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: A novel experimental model for hemopoietic lineage restriction. Exp Hematol 21:525, 1993
27. Ito E, Kasai M, Hayashi Y, Toki T, Arai K, Yokoyama S, Kato K, Tachibana N, Yamamoto M, Yokoyama M: Expression of erythroid-specific genes in acute megakaryoblastic leukemia and transient myeloproliferative disorder in Down's syndrome. Br J Haematol 90:607, 1995
28. Drabkin HA, Erickson P: Down syndrome and leukemia, an update, in Epstein CJ, Hassold T, Lott IT, Nadel L, Patterson D (eds): Etiology and Pathogenesis of Down Syndrome. New York, Wiley-Liss, 1995, p 169
29. Avraham KB, Schickler M, Sazpoznikov D, Yarom R, Groner Y: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell 54:823, 1988
30. Sumarsono SH, Wilson TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A, Kola I: Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature 379:534, 1996
31. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12.8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986
32. Lu J, Maruykama M, Satake M, Bae S-C, Ogawa E, Kagohima H, Shigesada K, Ito Y: Subcellular localization of the a and b subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol Cell Biol 15:1651, 1995
33. Zhu X, Yeadon JE, Burden SJ: AML1 is expressed in skeletal muscle and is regulated by innervation. Mol Cell Biol 14:8051, 1994
34. Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y: Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development. Mol Cell Biol 15:1662, 1995
35. Satake M, Ibarbaki T, Yamaguchi Y, Ito Y: Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoyl-phorbol-13-acetate after transformation of NIH 3T3 cells by the Haras oncogene. J Virol 63:3669, 1989
36. Chang K-S, Fan Y-H, Stass SA, Estey EH, Wang G, Trujillo JM, Erickson P, Drabkin H: Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 8:983, 1993
37. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994